COVID Vaccine Initiative


The COVID Vaccine Initiative (CVI) aims to ensure the development of safe, effective, and accessible vaccines for those most vulnerable to COVID-19: aging populations and those living in low- and middle-income countries. It leverages HVP’s global clinical research consortium, including newly established collaborations with the Harvard T.H. Chan School of Public Health focused on deciphering effective immunity in aging populations; FHI 360, a global nonprofit research and human development organization with extensive experience working in low and middle-income countries; and the University of Minnesota’s Center for Infectious Disease Research and Policy, a global leader in addressing public health preparedness and emerging infectious disease response.

COVID Newsroom

Global COVID Lab Meeting

Oct 08, 2020

Emanuele Andreano

Toscana Life Sciences

Global COVID Lab Meeting

Oct 01, 2020

The Forum

Harvard T.H. Chan School of Public Health

Global COVID Lab Meeting

Sep 24, 2020

Sarah Gilbert

Jenner Institute University of Oxford

Global COVID Lab Meeting

Sep 10, 2020

John Wherry

University of Pennsylvania

Global COVID Lab Meeting

Aug 27, 2020

Michael Farzan

The Scripps Research Institute

Global COVID Lab Meeting

Aug 13, 2020

Dan Barouch

Harvard, Beth Israel Deaconess Medical Center